Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis

被引:17
作者
Yu, Shao-Nan [1 ]
Liu, Gui-Feng [1 ]
Li, Xue-Feng [2 ]
Fu, Bao-Hong [1 ]
Dong, Li-Xin [2 ]
Zhang, Shu-Hua [3 ]
机构
[1] Jilin Univ, Dept Radiol, China Japan Union Hosp, Changchun 130033, Jilin, Peoples R China
[2] Jilin Univ, Dept Anesthesiol, China Japan Union Hosp, Changchun 130033, Jilin, Peoples R China
[3] Jilin Univ, China Japan Union Hosp, Operating Room, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China
关键词
NON-SMALL CELL LUNG CANCER; DNA REPAIR GENE; POLYMORPHISM; PLATINUM-BASED CHEMOTHERAPY; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISMS; ADVANCED NSCLC PATIENTS; 1ST-LINE CHEMOTHERAPY; XRCC1; ARG399GLN; SURVIVAL; CISPLATIN; ERCC1; ASSOCIATION; XPD; GEMCITABINE;
D O I
10.1002/jcb.26147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This network meta-analysis (NMA) was conducted to compare the predictive value of 14 SNPs in eight DNA repair genes on the efficacy of platinum-based chemotherapy in patients with non-small cell lung cancer (NSCLC). These included ERCC1 (rs11615, rs3212986, rs3212948), XRCC1 (rs25487, rs25489, rs1799782), XPD (rs13181, rs1799793), XPG (rs1047768, rs17655), XPA (rs1800975), XRCC3 (rs861539), APE1 (rs3136820), and RRM1 (rs1042858). The PubMed and Cochrane library databases were reviewed from their inception to February 2017 and studies which met our inclusion criteria were included in our investigation. This network meta-analysis combines direct and indirect evidence to assess the predictive value of 14 SNPs in eight DNA repair genes on the efficacy of platinum-based chemotherapy in NSCLC. We evaluated the predictive value through the use of the odd ratios (OR) and drawing surface under the cumulative ranking curves (SUCRA). A total of 26 eligible cohort studies were enrolled in this NMA. The pairwise meta-analysis indicated that in terms of overall response ratio (ORR), ERCC1 (rs11615), XRCC1 (rs25487, rs1799782), and XPD (rs13181) polymorphisms are associated with the efficacy of platinum-based chemotherapy in NSCLC. The result of this NMA suggests that there is no significant difference in predictive value of 8 DNA repair genes on the efficacy of platinum-based chemotherapy in NSCLC patients. The rank of SUCRA values of the 14 SNPs in the eight DNA repair genes were: XPD (rs1799793)ERCC1 (rs3212986)XPA(rs1800975)ERCC1(rs3212948)XRCC1(rs25487)XRCC3(rs861539)APE1(rs3136820)ERCC1(rs11615)XRCC1(rs1799782)RRM1(rs1042858)XPD(rs13181)XPG (rs1047768)XPG(rs17655)XRCC1(rs25489). ERCC1(rs11615), XRCC1(rs25487, rs1799782) and XPD(rs13181) polymorphisms were better predictors in evaluating the efficacy of platinum-based chemotherapy in NSCLC patients. J. Cell. Biochem. 118: 4782-4791, 2017. (c) 2017 Wiley Periodicals, Inc.
引用
收藏
页码:4782 / 4791
页数:10
相关论文
共 48 条
[1]   Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer [J].
Ai, Dan ;
Guan, Yan ;
Liu, Xiu-Ju ;
Zhang, Chu-Feng ;
Wang, Peng ;
Liang, Hong-Lu ;
Guo, Qi-Sen .
ONCOTARGETS AND THERAPY, 2016, 9 :5693-5698
[2]   Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapyin advanced nonsmall cell lung cancer [J].
Booton, Richard ;
Ward, Tim ;
Heighway, Jim ;
Taylor, Pat ;
Power, Fiona ;
Ashcroft, Linda ;
Morris, Julie ;
Thatcher, Nicholas .
CANCER, 2006, 106 (11) :2421-2427
[3]   Hypofractionated proton beam radiotherapy for stage I lung cancer [J].
Bush, DA ;
Slater, JD ;
Shin, BB ;
Cheek, G ;
Miller, DW ;
Slater, JM .
CHEST, 2004, 126 (04) :1198-1203
[4]   Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy [J].
Butkiewicz, Dorota ;
Drosik, Anna ;
Suwinski, Rafal ;
Krzesniak, Malgorzata ;
Rusin, Marek ;
Kosarewicz, Agata ;
Rachtan, Jadwiga ;
Matuszczyk, Iwona ;
Gawkowska-Suwinska, Marzena .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (07) :E1100-E1108
[5]   ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine [J].
Ceppi, P. ;
Volante, M. ;
Novello, S. ;
Rapa, I. ;
Danenberg, K. D. ;
Danenberg, P. V. ;
Cambieri, A. ;
Selvaggi, G. ;
Saviozzi, S. ;
Calogero, R. ;
Papotti, M. ;
Scagliotti, G. V. .
ANNALS OF ONCOLOGY, 2006, 17 (12) :1818-1825
[6]   Graphical Tools for Network Meta-Analysis in STATA [J].
Chaimani, Anna ;
Higgins, Julian P. T. ;
Mavridis, Dimitris ;
Spyridonos, Panagiota ;
Salanti, Georgia .
PLOS ONE, 2013, 8 (10)
[7]   Hypoxia Provokes Base Excision Repair Changes and a Repair-Deficient, Mutator Phenotype in Colorectal Cancer Cells [J].
Chan, Norman ;
Ali, Mohsin ;
McCallum, Gordon P. ;
Kumareswaran, Ramya ;
Koritzinsky, Marianne ;
Wouters, Bradly G. ;
Wells, Peter G. ;
Gallinger, Steven ;
Bristow, Robert G. .
MOLECULAR CANCER RESEARCH, 2014, 12 (10) :1407-1415
[8]   Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients [J].
Chen, Xiaoxia ;
Sun, Hui ;
Ren, Shengxiang ;
Curran, Vikramsingh Kim ;
Zhang, Ling ;
Zhou, Songwen ;
Zhang, Jie ;
Zhou, Caicun .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (03) :207-213
[9]   XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer [J].
Feng, Jifeng ;
Sun, Xinchen ;
Sun, Ning ;
Qin, Shukui ;
Li, Fan ;
Cheng, Hongyan ;
Chen, Baoan ;
Cao, YuanDong ;
Ma, Jun ;
Cheng, Lu ;
Lu, Zuhong ;
Ji, Jiazhong ;
Zhou, Yingfeng .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2009, 41 (05) :429-435
[10]   DNA repair and survival in lung cancer - The two faces of Janus [J].
Gazdar, Adi F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :771-773